Implementing a new scale for failure mode and effects analysis (FMEA) for risk analysis in a radiation oncology department
Standard
Implementing a new scale for failure mode and effects analysis (FMEA) for risk analysis in a radiation oncology department. / Baehr, Andrea; Oertel, Michael; Kröger, Kai; Eich, Hans Theodor; Haverkamp, Uwe.
in: STRAHLENTHER ONKOL, Jahrgang 196, Nr. 12, 12.2020, S. 1128-1134.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Implementing a new scale for failure mode and effects analysis (FMEA) for risk analysis in a radiation oncology department
AU - Baehr, Andrea
AU - Oertel, Michael
AU - Kröger, Kai
AU - Eich, Hans Theodor
AU - Haverkamp, Uwe
PY - 2020/12
Y1 - 2020/12
N2 - PURPOSE: Patients and staffs are endangered by different failure modes during clinical routine in radiation oncology and risks are difficult to stratify. We implemented the method of failure mode and effects analysis (FMEA) via questionnaires in our institution and introduced an adapted scale applicable for radiation oncology.METHODS: Failure modes in physical treatment planning and daily routine were detected and stratified by ranking occurrence, severity, and detectability in a questionnaire. Multiplication of these values offers the risk priority number (RPN). We implemented an ordinal rating scale (ORS) as a combination of earlier published scales from the literature. This scale was optimized for German radiation oncology. We compared RPN using this ORS versus use of a rather subjective visual analogue rating scale (VRS).RESULTS: Mean RPN using ORS was 62.3 vs. 67.5 using VRS (p = 0.7). Use of ORS led to improved completeness of questionnaires (91 vs. 79%) and stronger agreement among the experts, especially concerning failure modes during radiation routine. The majority of interviewed experts found the analysis by using the ORS easier and expected a saving of time as well as higher intra- and interobserver reliability.CONCLUSION: The introduced rating scale together with a questionnaire survey provides merit for conducting FMEA in radiation oncology as results are comparable to the use of VRS and the process is facilitated.
AB - PURPOSE: Patients and staffs are endangered by different failure modes during clinical routine in radiation oncology and risks are difficult to stratify. We implemented the method of failure mode and effects analysis (FMEA) via questionnaires in our institution and introduced an adapted scale applicable for radiation oncology.METHODS: Failure modes in physical treatment planning and daily routine were detected and stratified by ranking occurrence, severity, and detectability in a questionnaire. Multiplication of these values offers the risk priority number (RPN). We implemented an ordinal rating scale (ORS) as a combination of earlier published scales from the literature. This scale was optimized for German radiation oncology. We compared RPN using this ORS versus use of a rather subjective visual analogue rating scale (VRS).RESULTS: Mean RPN using ORS was 62.3 vs. 67.5 using VRS (p = 0.7). Use of ORS led to improved completeness of questionnaires (91 vs. 79%) and stronger agreement among the experts, especially concerning failure modes during radiation routine. The majority of interviewed experts found the analysis by using the ORS easier and expected a saving of time as well as higher intra- and interobserver reliability.CONCLUSION: The introduced rating scale together with a questionnaire survey provides merit for conducting FMEA in radiation oncology as results are comparable to the use of VRS and the process is facilitated.
KW - Germany
KW - Healthcare Failure Mode and Effect Analysis/methods
KW - Humans
KW - Neoplasms/radiotherapy
KW - Radiation Oncology/methods
KW - Radiotherapy Planning, Computer-Assisted/methods
KW - Surveys and Questionnaires
KW - Workflow
U2 - 10.1007/s00066-020-01686-w
DO - 10.1007/s00066-020-01686-w
M3 - SCORING: Journal article
C2 - 32951162
VL - 196
SP - 1128
EP - 1134
JO - STRAHLENTHER ONKOL
JF - STRAHLENTHER ONKOL
SN - 0179-7158
IS - 12
ER -